Ringdén O - Search Results

1

Is there a stronger graft-versus-leukemia effect using HLA-haploidentical donors compared with HLA-identical siblings?

Ringdén O, Labopin M, Ciceri F, Velardi A, Bacigalupo A, Arcese W, Ghavamzadeh A, Hamladji RM, Schmid C, Nagler A, Mohty M. Ringdén O, et al. Leukemia. 2016 Feb;30(2):447-55. doi: 10.1038/leu.2015.232. Epub 2015 Aug 21. Leukemia. 2016. PMID: 26293645

2

Decreased incidence of graft-versus-host disease and improved survival with methotrexate combined with cyclosporin compared with monotherapy in recipients of bone marrow from donors other than HLA identical siblings.

Ringdén O, Klaesson S, Sundberg B, Ljungman P, Lönnqvist B, Persson U. Ringdén O, et al. Bone Marrow Transplant. 1992 Jan;9(1):19-25. Bone Marrow Transplant. 1992. PMID: 1543946

3

Strong donor mononuclear cell reactivity for herpes simplex virus (HSV) antigen in HSV immune donors combined with recipient seropositivity for HSV is associated with acute graft-versus-host disease.

Boström L, Ringdén O, Forsgren M. Boström L, et al. Among authors: ringden o. Scand J Immunol. 1991 Jul;34(1):45-52. doi: 10.1111/j.1365-3083.1991.tb01519.x. Scand J Immunol. 1991. PMID: 1648786

4

Methotrexate combined with cyclosporin A decreases graft-versus-host disease, but increases leukemic relapse compared to monotherapy.

Aschan J, Ringdén O, Sundberg B, Gahrton G, Ljungman P, Winiarski J. Aschan J, et al. Among authors: ringden o. Bone Marrow Transplant. 1991 Feb;7(2):113-9. Bone Marrow Transplant. 1991. PMID: 2049554 Clinical Trial.

5

Graft-versus-leukemia reactions after bone marrow transplantation.

Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, Rimm AA, Ringdén O, Rozman C, Speck B, et al. Horowitz MM, et al. Among authors: ringden o. Blood. 1990 Feb 1;75(3):555-62. Blood. 1990. PMID: 2297567 Free article.

6

DNA synthesis in human blood mononuclear cells correlates with severity of acute graft-versus-host disease.

Ringdén O. Ringdén O. Bone Marrow Transplant. 1987 Oct;2(3):259-69. Bone Marrow Transplant. 1987. PMID: 2844339

7

Pretransplant herpesvirus serology and acute graft-versus-host disease.

Boström L, Ringdén O, Sundberg B, Linde A, Tollemar J, Nilsson B. Boström L, et al. Among authors: ringden o. Transplantation. 1988 Oct;46(4):548-52. doi: 10.1097/00007890-198810000-00016. Transplantation. 1988. PMID: 2845612

8

Ringdén O, Remberger M, Persson U, Ljungman P, Aldener A, Andström E, Aschan J, Bolme P, Dahllöf G, Dalianis T, et al. Ringdén O, et al. Bone Marrow Transplant. 1995 Apr;15(4):619-25. Bone Marrow Transplant. 1995. PMID: 7655390

9

Individualized prophylaxis against graft-versus-host disease in leukemic marrow transplant recipients.

Aschan J, Ringdén O, Andström E, Ljungman P, Lönnqvist B, Remberger M. Aschan J, et al. Among authors: ringden o. Bone Marrow Transplant. 1994 Jul;14(1):79-87. Bone Marrow Transplant. 1994. PMID: 7951124 Clinical Trial.

10

Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease.

Aschan J, Ringdén O. Aschan J, et al. Among authors: ringden o. Clin Transplant. 1994 Jun;8(3 Pt 1):258-70. Clin Transplant. 1994. PMID: 8061365

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

766 results

Search Page

Filters